| Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor AL Lazaar, L Yang, RL Boardley, NS Goyal, J Robertson, SJ Baldwin, ... British journal of clinical pharmacology 81 (5), 971-979, 2016 | 163 | 2016 |
| Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects N Goyal, P Skrdla, R Schroyer, S Kumar, D Fernando, A Oughton, ... American Journal of Cardiovascular Drugs 19 (3), 335-342, 2019 | 119 | 2019 |
| Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660) BE Miller, RJ Mayer, N Goyal, J Bal, N Dallow, M Boyce, D Carpenter, ... British Journal of Clinical Pharmacology 83 (12), 2813-2820, 2017 | 59 | 2017 |
| Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects JA Green, K Mohamed, N Goyal, S Bouhired, A Hussaini, SW Jones, ... Antimicrobial Agents and Chemotherapy 60 (12), 7321-7332, 2016 | 34 | 2016 |
| Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease N Goyal, M Beerahee, C Kalberg, A Church, S Kilbride, R Mehta Clinical Pharmacokinetics 53 (7), 637-648, 2014 | 34 | 2014 |
| Artificial Intelligence (AI) and Pharmacometrics: Time to Embrace, Capitalize and Advance? A Chaturvedula, S Calad‐Thomson, C Liu, M Sale, N Gattu, N Goyal CPT: Pharmacometrics & Systems Pharmacology, 2019 | 33 | 2019 |
| Evaluation of the Administration Time Effect on the Cumulative Cortisol Suppression and Cumulative Lymphocytes Suppression for Once‐Daily Inhaled Corticosteroids: A Population … K Wu, N Goyal, JG Stark, G Hochhaus The Journal of Clinical Pharmacology 48 (9), 1069-1080, 2008 | 24 | 2008 |
| Population Pharmacokinetics of Tafenoquine, a Novel Anti-Malarial N Thakkar, JA Green, GCKW Koh, S Duparc, D Tenero, N Goyal Antimicrobial Agents and Chemotherapy 62 (11), AAC. 00711-18, 2018 | 21 | 2018 |
| Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria D Tenero, JA Green, N Goyal Antimicrobial agents and chemotherapy 59 (10), 6188-6194, 2015 | 16 | 2015 |
| A latent variable approach in simultaneous modeling of longitudinal and dropout data in schizophrenia trials N Goyal, R Gomeni European Neuropsychopharmacology 23 (11), 1570-1576, 2013 | 15 | 2013 |
| Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre … ID Vélez, TT Hien, JA Green, A Martin, H Sharma, VM Rousell, JJ Breton, ... The Lancet Child & Adolescent Health 6 (2), 86-95, 2022 | 14 | 2022 |
| Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology MH Shahin, A Barth, JT Podichetty, Q Liu, N Goyal, JY Jin, D Ouellet Clinical Pharmacology & Therapeutics, 2023 | 13 | 2023 |
| Simultaneous Determination of Dexamethasone, Dexamethasone 21‐Acetate, and Paclitaxel in a Simulated Biological Matrix by RP‐HPLC: Assay Development and Validation N Goyal, A El Achchabi, E Goldberg, G Hochhaus Journal of Liquid Chromatography & Related Technologies 31 (10), 1478-1491, 2008 | 13 | 2008 |
| Demonstrating bioequivalence using pharmacokinetics: theoretical considerations across drug classes N Goyal, G Hochhaus Respir Drug Deliv 201 (1), 261-268, 2010 | 11 | 2010 |
| Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and … I Sutanto, A Soebandrio, LL Ekawati, K Chand, R Noviyanti, ... The Lancet Infectious Diseases 23 (10), 1153-1163, 2023 | 10 | 2023 |
| A novel methodology to estimate the treatment effect in presence of highly variable placebo response R Gomeni, N Goyal, F Bressolle, M Fava CLINICAL PHARMACOLOGY & THERAPEUTICS 97, S71-S71, 2015 | 10 | 2015 |
| Dose–response modelling of umeclidinium and fluticasone furoate/umeclidinium in asthma S Yang, N Goyal, M Beerahee, R Trivedi, L Lee, S Pascoe European journal of clinical pharmacology 71 (9), 1051-1058, 2015 | 9 | 2015 |
| A novel metric to assess the clinical utility of a drug in the presence of efficacy and dropout information N Goyal, R Gomeni Clinical Pharmacology & Therapeutics 91 (2), 215-219, 2012 | 9 | 2012 |
| A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study SS Bachhav, M Taylor, A Martin, JA Green, S Duparc, K Rolfe, H Sharma, ... British Journal of Clinical Pharmacology 89 (3), 1187-1197, 2023 | 7 | 2023 |
| Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development M Siemons, B Schroyen, N Darville, N Goyal The AAPS Journal 25 (6), 99, 2023 | 6 | 2023 |
